The global next generation sequencing market is set to witness a growth rate of ~15% in the next 5 years. Rising demand for ...

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the ...

Market Research Report Highlights Key Trends, Drivers, and InnovationsThe DNA sequencing market has emerged as a cornerstone ...

Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% ...

Life sciences company Element Biosciences sued Illumina on Monday in separate cases in federal courts in California and ...

Enzymes are important tools, and a new technology combining microbiology and AI has exciting potential to advance their use in many applications ...

"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) ...

This eBook will go beyond just talking about how to streamline manufacturing but also provide in-depth insights into topics that aren’t always covered to the same degree but are just as important to ...

Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration ...